Rwanda's Marburg cases decline but mpox spreading in Africa, health officials say
October 17, 2024
Rwanda's Marburg virus outbreak is declining following vaccinations of vulnerable groups, with new infections reduced by over 50%. The country reports 62 confirmed cases, 15 deaths, and 38 recoveries. Meanwhile, the mpox outbreak continues to spread across Africa, now affecting 18 African Union member states, up from six in April. Africa CDC reports over 42,000 suspected mpox cases and 1,100 deaths this year. Despite $800 million pledged to fight mpox, donors are slow to provide actual funds and vaccines. Health officials stress the need for intensified efforts to prevent further spread across the continent.
Rwanda is seeing positive results in its fight against the Marburg virus outbreak, while the African continent continues to grapple with the spreading mpox epidemic. This dual health crisis highlights both progress and ongoing challenges in Africa's public health landscape.
Marburg Virus in Rwanda:
1. Vaccination campaign: Initiated in early October, targeting vulnerable groups including healthcare workers.
2. Significant decline: New infections reduced by over 50% compared to the first two weeks of the outbreak.
3. Current statistics: 62 confirmed cases, 15 deaths, 38 recoveries, and 9 under treatment.
4. Positive trend: Consecutive days without new cases or deaths reported.
5. Health Minister Sabin Nsanzimana describes the situation as "very encouraging" with declining infections and mortality rates.
Mpox Outbreak in Africa:
1. Continued spread: The World Health Organization has declared it a public health emergency of international concern.
2. Increasing reach: Affected countries rose from 6 to 18 African Union member states between April and October.
3. Alarming numbers: Over 42,000 suspected cases and 1,100 deaths reported across Africa in 2024.
4. Funding challenges: Despite $800 million pledged, there's a delay in translating promises into actual funds and vaccines.
5. Jean Kaseya, director general of Africa CDC, emphasizes the need to intensify efforts to prevent further spread.
The contrasting situations of the Marburg virus in Rwanda and mpox across Africa underscore the importance of rapid, targeted responses to disease outbreaks. Rwanda's success in controlling Marburg through vaccination and treatment offers a model for effective epidemic management. However, the persistent spread of mpox highlights the challenges of coordinating responses across multiple countries and the critical need for timely funding and resource allocation in public health emergencies. The situation calls for continued vigilance, international cooperation, and prompt action to address emerging health threats in Africa.